Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New antimicrobial drugs: an update].

Heinz Burgmann1

  • 1Klinische Abteilung für Infektionen und Chemotherapie, Universitätsklinik für Innere Medizin I, Währinger Gürtel 18-20, A-1090 Wien. heinz.burgmann@univie.ac.at

Wiener Medizinische Wochenschrift (1946)
|May 27, 2003
PubMed
Summary

Antimicrobial resistance is a growing concern. This review explores novel antimicrobial agents and strategies to combat resistance, including new drug classes and treatment approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.

Antibiotics (Basel, Switzerland)·2026
Same author

Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study.

Virology journal·2026
Same author

Dysphagia Management is Associated with Reduced Mortality in Patients with Moderate to Severe Acute Ischemic Stroke.

Neurology and therapy·2025
Same author

Antimicrobial treatment for 7 versus 14 days in patients with bacteremia: a meta-analysis of randomized controlled trials.

Infection·2025
Same author

Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalized adults with COVID-19: a population-based, retrospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024
Same author

Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency : A prospective controlled open-label trial.

Wiener klinische Wochenschrift·2024

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Context:

  • Antimicrobial resistance (AMR) poses a significant global health threat.
  • Existing antimicrobial therapies face challenges due to evolving resistance mechanisms.

Purpose:

  • To review current strategies for reducing antimicrobial resistance.
  • To highlight emerging antimicrobial substances with potential to overcome resistance.

Summary:

  • Discusses antimicrobial restriction, microbial monitoring, and calculated antimicrobial treatment as key control measures.
  • Examines novel antimicrobial classes including carbapenems, quinolones, ketolides, oxazolidinones, glycylcyclines, echinocandins, and azoles.

Impact:

  • Provides an overview of the latest advancements in antimicrobial drug development.
  • Informs strategies for managing and mitigating the impact of antimicrobial resistance.

Related Experiment Videos